{"id":6705,"date":"2021-11-20T20:04:04","date_gmt":"2021-11-20T20:04:04","guid":{"rendered":"https:\/\/www.ingilizcemakaleyazimi.com\/?page_id=6705"},"modified":"2022-03-01T03:54:28","modified_gmt":"2022-03-01T03:54:28","slug":"bolum-5-dergi-ile-iletisim","status":"publish","type":"page","link":"https:\/\/www.ingilizcemakaleyazimi.com\/?page_id=6705","title":{"rendered":"B\u00f6l\u00fcm 5: Dergi \u0130le \u0130leti\u015fim"},"content":{"rendered":"

SAYFA YAPIM A\u015eAMASINDA. HEN\u00dcZ SON HAL\u0130N\u0130 ALMADI.<\/strong><\/span><\/p>\n

 <\/p>\nMakale de\u011ferlendirme s\u00fcreci hakk\u0131nda genel bilgi (YAPIM A\u015eAMASINDA)<\/strong><\/span>

\n

 <\/p>\n

Haz\u0131rlan\u0131yor<\/span><\/p>\n<\/div>\n

 <\/p>\nKapak mektubu (cover letter<\/em>) yaz\u0131m\u0131:<\/strong><\/span>

\n

 <\/p>\n

Hemen hemen t\u00fcm dergilerde haz\u0131rlanan makalenin dergiye g\u00f6nderilmesi esnas\u0131nda edit\u00f6re y\u00f6nelik olarak yaz\u0131lm\u0131\u015f bir mektup da sisteme y\u00fcklenir. Makaleden sorumlu yazar taraf\u0131ndan haz\u0131rlanan kapak mektubunda makalenin yazarlar\u0131 ve ba\u015fl\u0131\u011f\u0131 belirtilir. Bunun yan\u0131 s\u0131ra makalenin g\u00f6nderildi\u011fi derginin Yazarlara Bilgiler (Instructions for Authors<\/em>) sayfas\u0131nda talep etti\u011fi di\u011fer bilgilere de (makalenin daha \u00f6nce yay\u0131nlanmad\u0131\u011f\u0131 ve \u015fu anda herhangi bir dergide hakem de\u011ferlendirmesinde olmad\u0131\u011f\u0131, makaleye yazar olarak yaz\u0131lan ara\u015ft\u0131rmac\u0131lar\u0131n tamam\u0131n\u0131n \u00e7al\u0131\u015fmaya yazar olmay\u0131 hak ettirecek derecede katk\u0131 yapt\u0131\u011f\u0131, yazarlar\u0131n tamam\u0131n\u0131n makalenin son halini g\u00f6rd\u00fc\u011f\u00fc ve yay\u0131nlanmas\u0131na onay verdi\u011fi, yazarlar\u0131n herhangi bir \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 olmad\u0131\u011f\u0131 gibi) kapak mektubunda yer verilir. Bu bilgilerden baz\u0131lar\u0131n\u0131 haz\u0131rlad\u0131klar\u0131 formlarla (\u00f6rne\u011fin t\u00fcm yazarlar\u0131n isimlerinin ve imzalar\u0131n\u0131n yer ald\u0131\u011f\u0131 makale onay formu) isteyen dergiler de vard\u0131r.<\/p>\n

Pek \u00e7ok yazar taraf\u0131ndan gereksiz bir zorunluluk olarak g\u00f6r\u00fclen kapak mektubu asl\u0131nda yazarlar\u0131n makalelerinin reklam\u0131n\u0131 yapabilecekleri \u00e7ok uygun bir ara\u00e7t\u0131r. En ilgili dergi edit\u00f6r\u00fc dahi, dergisine g\u00f6nderilen t\u00fcm makaleleri ba\u015ftan a\u015fa\u011f\u0131 okuyacak kadar zamana ve t\u00fcm makalelerin bilimsel i\u00e7eri\u011fini de\u011ferlendirebilecek bilgi birikimine sahip de\u011fildir. \u00c7o\u011fu kez yap\u0131lan uygulama, edit\u00f6r\u00fcn (ya da yard\u0131mc\u0131 edit\u00f6rlerin) makaleye genel olarak g\u00f6z att\u0131ktan sonra, makalenin \u00f6zellikle \u00d6zet, Materyal-Metod, Sonu\u00e7lar ve Tart\u0131\u015fma k\u0131s\u0131mlar\u0131n\u0131 incelemeleridir. \u0130yi yaz\u0131lm\u0131\u015f bir kapak mektubu yazarlara i\u015fte bu a\u015famada \u00e7ok b\u00fcy\u00fck avantaj sa\u011flayabilir. Sorumlu yazar yapt\u0131klar\u0131 \u00e7al\u0131\u015fmadan elde ettikleri \u00e7arp\u0131c\u0131 sonu\u00e7lar\u0131 ve makalenin bu alandaki bilgi a\u00e7\u0131\u011f\u0131n\u0131 nas\u0131l kapayabilece\u011fini kapak mektubunda birka\u00e7 c\u00fcmle ile \u00f6zetleyerek, k\u0131sa bir s\u00fcre i\u00e7erisinde makale ile ilgili bir \u00f6n karar vermek durumunda olan edit\u00f6re (ya da yard\u0131mc\u0131 edit\u00f6rlere) uzun bir makale i\u00e7erisinde aramak zorunda oldu\u011fu bilgileri sunabilir. Makalenin standart olarak haz\u0131rlanm\u0131\u015f olan \u00d6zetinden farkl\u0131 olarak kapak mektubunda yazarlar\u0131n makalelerinin reklam\u0131n\u0131 yapabilecekleri c\u00fcmleleri kurmas\u0131 \u00e7ok daha kolay olacakt\u0131r. Edit\u00f6rlerin g\u00f6z\u00fcnde iyi haz\u0131rlanm\u0131\u015f kapak mektuplar\u0131 \u00e7ok de\u011ferlidir ve iyi haz\u0131rlanm\u0131\u015f bir kapak mektubu bir makalenin \u00f6n de\u011ferlendirmesine \u00e7ok olumlu katk\u0131 yapar. Dolay\u0131s\u0131yla yazarlar\u0131n bu konunun fark\u0131nda olmas\u0131 ve kapak mektubu haz\u0131rlamaya \u00f6zen g\u00f6stermesi yerinde olacakt\u0131r.<\/p>\n

A\u015fa\u011f\u0131da makalenizi ilk kez g\u00f6nderirken edit\u00f6re yazabilece\u011finiz \u00f6rnek bir kapak mektubunu ve daha alt\u0131nda bu kapak mektubuna yazabilece\u011finiz \u00f6rnek c\u00fcmleleri bulabilirsiniz:<\/p>\n

Kapak mektubunu word dosyas\u0131 olarak indir<\/a>:<\/span><\/p>\n

 <\/p>\n

*********************<\/p>\n

Dear Editor,<\/p>\n

Enclosed, please find our manuscript entitled \u201cEffects of a novel substance A on blood pressure of hypertensive geriatric patients\u201d written by Grinwis GC, van Garderen E, and Dorrestein GM. In this study, we investigated the blood pressure decreasing effects of a novel Substance A in hypertensive geriatric patients. Dramatic decreases were observed when compared with the control group. Substance A also had significantly fewer side effects than the control Substance X, one of the most commonly used antihypertensive medications in geriatric patients. Additionally, Substance A has a lower cost than all the currently available antihypertensive drugs. We, therefore, believe that our manuscript has scientific merit and deserves publication.<\/p>\n

The manuscript has been written according to the guidelines of Journal of XXX, and has been read and approved by all the authors. The findings have not been presented or submitted elsewhere.<\/p>\n

We look forward to hearing from you soon.<\/p>\n

Sincerely yours,<\/p>\n

 <\/p>\n

Prof.Dr. Guy C. Grinwis<\/p>\n

************************<\/p>\n

Kapak mektubuna yazabilece\u011finiz c\u00fcmle alternatifleri:<\/strong><\/p>\n

 <\/p>\n

Dear Editor,<\/span><\/p>\n

Burada isterseniz edit\u00f6re ismen de hitap edebilirsiniz. \u00d6rne\u011fin:<\/p>\n

Dear Prof.Dr. Smith,<\/p>\n

—————————————————————————<\/p>\n

Enclosed, please find our manuscript entitled \u201cEffects of a novel substance A on blood pressure of hypertensive geriatric patients\u201d written by Grinwis GC, van Garderen E, and Dorrestein GM.<\/span><\/p>\n

Bu k\u0131s\u0131m makalenin ba\u015fl\u0131\u011f\u0131n\u0131n ve yazarlar\u0131n\u0131n belirtildi\u011fi k\u0131s\u0131md\u0131r.<\/p>\n

—————————————————————————<\/p>\n

In this study, we investigated the blood pressure decreasing effects of a novel Substance A in hypertensive geriatric patients. Dramatic decreases were observed when compared with the control group. Substance A also had significantly fewer side effects than the control Substance X, one of the most commonly used antihypertensive medications in geriatric patients. Additionally, Substance A has a lower cost than all the currently available antihypertensive drugs.<\/span><\/p>\n

Makalenin ba\u015fl\u0131\u011f\u0131n\u0131n ve yazarlar\u0131n\u0131n belirtilmesinin ard\u0131ndan kapak mektubunu \u00f6nemli k\u0131lan k\u0131s\u0131m yani \u00e7al\u0131\u015fman\u0131n en \u00f6nemli bulgular\u0131n\u0131n vurgulanmas\u0131 gelir. Bu k\u0131s\u0131mda birka\u00e7 c\u00fcmle ile \u00e7al\u0131\u015fman\u0131zdan elde etti\u011finiz \u00f6nemli sonu\u00e7lardan bahsedin. Bu k\u0131s\u0131mda kullanabilece\u011finiz baz\u0131 di\u011fer \u00f6rnek c\u00fcmle kal\u0131plar\u0131:<\/p>\n

In addition to what is known, our study proves that …<\/p>\n

In this study, we, for the first time, demonstrated that …<\/p>\n

The present study is the first to …<\/p>\n

Results generated from this study will hopefully contribute to our current understanding of …<\/p>\n

 <\/p>\n

Bu k\u0131s\u0131mda yazabilece\u011finiz \u00e7ok daha fazla c\u00fcmleyi B\u00f6l\u00fcm 3: B\u00f6l\u00fcmler Halinde Makale Yaz\u0131m\u0131 <\/a><\/span>k\u0131sm\u0131nda Tart\u0131\u015fma ba\u015fl\u0131\u011f\u0131 alt\u0131nda bulabilirsiniz.<\/p>\n

—————————————————————————<\/p>\n

We, therefore, believe that our manuscript has scientific merit and deserves publication.<\/span><\/p>\n

\u00c7al\u0131\u015fman\u0131z\u0131n en \u00f6nemli bulgular\u0131ndan bahsettikten sonra \u00e7al\u0131\u015fman\u0131z\u0131n bu sebeplerden dolay\u0131 yay\u0131nlanmay\u0131 hak etti\u011fini vurgulayabilirsiniz.<\/p>\n

—————————————————————————<\/p>\n

The manuscript has been written according to the guidelines of Journal of XXX, and has been read and approved by all the authors. The findings have not been presented or submitted elsewhere.<\/span><\/p>\n

Bu k\u0131s\u0131mda yazman\u0131z gereken bilgileri derginin Internet sayfas\u0131nda Yazarlara Bilgiler (Instructions for Authors<\/em>) k\u0131sm\u0131nda bulabilirsiniz. Yazabilece\u011finiz di\u011fer c\u00fcmleler:<\/p>\n

All authors contributed equally to the preparation of the manuscript:<\/p>\n

The manuscript has not been submitted or under consideration elsewhere.<\/p>\n

The authors declare no conflict of interest.<\/p>\n

 <\/p>\n

Baz\u0131 dergiler makalede yer alan her bir yazar\u0131n makalenin hangi a\u015famalar\u0131na katk\u0131da bulundu\u011fu bilgisinin de kapak mektubunda\u00a0yer almas\u0131n\u0131 ister. Bu ama\u00e7la kullanabilece\u011finiz baz\u0131 ifadeler:<\/p>\n

Author A planned the study and created the study design. Author B and Author C performed animal experiments. Author D performed the laboratory tests and the statistical analysis. Author A, Author B, and Author C prepared the manuscript together.<\/p>\n

 <\/p>\n

The conception of the idea and study design<\/p>\n

Animal experimentation<\/p>\n

Performance of the experiments<\/p>\n

Statistical analysis<\/p>\n

Writing the manuscript<\/p>\n

Critical review and editing of the manuscript<\/p>\n

Language editing<\/p>\n

Bu k\u0131s\u0131mda yazabilece\u011finiz \u00e7ok daha fazla ifadeyi B\u00f6l\u00fcm 3: B\u00f6l\u00fcmler Halinde Makale Yaz\u0131m\u0131 <\/a><\/span>k\u0131sm\u0131nda bulabilirsiniz.<\/p>\n

 <\/p>\n

Baz\u0131 dergiler yazarlardan kapak mektubunda makalelerini de\u011ferlendirebilecek potansiyel hakem isimleri (ve bazen de hakemlik yapmas\u0131n\u0131 istemedikleri isimleri) \u00f6nermelerini isterler. Bu ama\u00e7la \u015f\u00f6yle c\u00fcmleler kurabilirsiniz:<\/p>\n

We believe that Dr. Arthur Green (University of Michigan, e-mail: a.green@……), Dr. Michael Black (University of Leeds, e-mail: m.black@…..), and Dr. John Red (University of Kentucky, e-mail: j.red@……….) would be suitable names to review our manuscript.<\/p>\n

We would like to suggest Dr. Arthur Green (University of Michigan, e-mail: a.green@……), and Dr. Michael Black (University of Leeds, e-mail: m.black@…..) as potential reviewers to evaluate our manuscipt, whereas we would kindly request Dr. John Red (University of Kentucky, e-mail: j.red@……….) not to be appointed as a reviewer due to our similar research areas and interest conflicts.<\/p>\n

—————————————————————————<\/p>\n

We look forward to hearing from you soon.<\/span><\/p>\n

Sincerely yours,<\/span><\/p>\n

Prof.Dr. Guy C. Grinwis<\/span><\/p>\n

Bu k\u0131s\u0131m da kapak mektubunun kapan\u0131\u015f k\u0131sm\u0131d\u0131r.<\/p>\n<\/div>\n

 <\/p>\nDergiden uzun s\u00fcre haber alamazsan\u0131z edit\u00f6re yazabilece\u011finiz mesaj \u00f6rne\u011fi:<\/strong><\/span>

\n

 <\/p>\n

Dergiye g\u00f6nderilen bir makalenin dergi taraf\u0131ndan de\u011ferlendirilmesi ve yazarlara ilk yan\u0131t\u0131n verilmesi i\u00e7in ge\u00e7en s\u00fcre haftalarla aylar aras\u0131nda de\u011fi\u015fkenlik g\u00f6sterebilir. Makalenizi g\u00f6nderdikten sonra makul olarak de\u011ferlendirdi\u011finiz bir s\u00fcrede dergiden haber alamad\u0131ysan\u0131z dergiye ya da e\u011fer e-posta adresleri belirtilmi\u015fse edit\u00f6re\/yard\u0131mc\u0131 edit\u00f6rlere mesaj g\u00f6ndererek makalenizin de\u011ferlendirme s\u00fcreci hakk\u0131nda bilgi isteyebilirsiniz.<\/p>\n

\u00d6rnek mesaj:<\/p>\n

************************<\/p>\n

Dear editor,<\/p>\n

On January 7, 2022, we submitted our manuscript entitled “Effect of Substance ABC on glycemic status, lipid profile, and total antioxidant capacity in hyperlipidemic type II diabetes mellitus patients: a randomized controlled trial” written by the authors Yilmaz R, Dagdeviren C, Aktay N, Cangul IT. So far we did not receive any information about the result of the evaluation process. We would be glad if you could kindly inform us if any progress has been made in the evaluation of our above mentioned manuscript.<\/p>\n

Sincerely yours,<\/p>\n

 <\/p>\n

Dr. Rahsan Yilmaz<\/p>\n

************************<\/p>\n<\/div>\n

 <\/p>\nRevizyon a\u015famas\u0131nda hakemlerin ele\u015ftirilerine cevap olarak yazabilece\u011finiz \u00f6rnek c\u00fcmleler:<\/strong><\/span>

\n

 <\/p>\n

Makalenizi bir dergiye g\u00f6nderdiniz ve makaleniz yay\u0131na kabul edildi, ancak hakemler makaleniz \u00fczerinde baz\u0131 de\u011fi\u015fikliklerin\/d\u00fczeltmelerin yap\u0131lmas\u0131n\u0131 istediler. B\u00f6yle bir durumda makalenizi revize ettikten sonra yapt\u0131\u011f\u0131n\u0131z de\u011fi\u015fikliklerle ilgili hakemlere bilgilendirici bir dosya g\u00f6ndermeniz gerekir. Yapt\u0131\u011f\u0131n\u0131z de\u011fi\u015fikliklerin hakemler taraf\u0131ndan kolayca anla\u015f\u0131lmas\u0131 i\u00e7in makalede ilgili yerlere ba\u015fka bir renkle vurgu yapabilir ya da buralar\u0131 farkl\u0131 bir yaz\u0131 tipi renginde yazabilirsiniz. Bunun yan\u0131 s\u0131ra hakemlerin ele\u015ftiri\/soru\/yorumlar\u0131n\u0131n madde madde olarak \u00fcstte yer ald\u0131\u011f\u0131, her maddenin alt\u0131nda da sizin cevab\u0131n\u0131z\u0131n yer ald\u0131\u011f\u0131 bir cevap dosyas\u0131 haz\u0131rlayabilirsiniz.<\/p>\n

A\u015fa\u011f\u0131da b\u00f6yle bir cevap dosyas\u0131na (b\u00f6yle bir dosyaya Authors\u2019 Response to Reviewers<\/em> ad\u0131 verebilirsiniz) yazabilece\u011finiz bir ba\u015flang\u0131\u00e7 metnini, alt\u0131nda da kullanabilece\u011finiz alternatif c\u00fcmleleri bulabilirsiniz.<\/p>\n

 <\/p>\n

***********<\/p>\n

AUTHORS\u2019 RESPONSE TO REVIEWERS<\/p>\n

We would like to thank the reviewers for their meticulous efforts in reviewing our manuscript. Their constructive criticisms and valuable comments helped us improve our manuscript. We performed all the suggested changes on the manuscript and marked them green. Below please find our point-by-point responses to other questions and comments of the reviewers.<\/p>\n

 <\/p>\n

Our response to Reviewer 1:<\/p>\n

TITLE<\/strong><\/p>\n

I suggest the authors include the study type in the title. The title can be: \u201cEffect of Substance ABC on glycemic status, lipid profile, and total antioxidant capacity in hyperlipidemic type II diabetes mellitus patients: A randomized controlled trial\u201d.<\/strong><\/p>\n

The title was changed as suggested by the reviewer.<\/p>\n

\u2026<\/p>\n

 <\/p>\n

****************<\/p>\n

Hakemlere te\u015fekk\u00fcr etmek i\u00e7in:<\/strong><\/p>\n

We would like to thank the reviewers for their valuable comments\/meticulous efforts\/constructive criticism.<\/u><\/p>\n

\u00a0<\/strong><\/p>\n

Hakem ele\u015ftirilerine cevap vermeye ba\u015flamadan \u00f6nce yazabilece\u011finiz giri\u015f c\u00fcmlesi:<\/strong><\/p>\n

Below please find our point-by-point responses to the reviewers\u2019 comments.<\/p>\n

 <\/p>\n

Hakemlerin d\u00fc\u015f\u00fcncelerini ifade etmek i\u00e7in:<\/strong><\/p>\n

The reviewer believes\/claims\/proposes\/suggests<\/u> that \u2026.. (since\/as) \u2026..<\/p>\n

The reviewer disagrees that \u2026.<\/p>\n

 <\/p>\n

Kendi d\u00fc\u015f\u00fcncenizi yazma \u00f6ncesi kullanabilece\u011finiz ba\u011fla\u00e7lar:<\/strong><\/p>\n

But<\/p>\n

However,<\/p>\n

On the other hand,<\/p>\n

 <\/p>\n

Hakemin d\u00fc\u015f\u00fcncesine k\u0131smen kat\u0131ld\u0131\u011f\u0131n\u0131z\u0131 belirtmek i\u00e7in: \u00a0<\/strong><\/p>\n

The reviewer claims that …… While this\/this statement\/this suggestion\/this observation<\/u> may be true, \u2026<\/p>\n

The reviewer has a point in thinking like that. However, \u2026<\/p>\n

The reviewer objects to the idea that \u2026\u2026 This is an understandable concern. However, \u2026.<\/p>\n

To a certain extent, the reviewer is correct in claiming that …… But\/However<\/u>, \u2026<\/p>\n

We agree with the reviewer that \u2026\u2026 But\/However<\/u> \u2026<\/p>\n

While it might be\/is<\/u> true that \u2026, still \u2026<\/p>\n

 <\/p>\n

Hakeme kat\u0131lmad\u0131\u011f\u0131n\u0131z\u0131 belirtmek i\u00e7in:<\/strong><\/p>\n

In our opinion, the argument claimed by the referee is not valid, because \u2026<\/p>\n

Unfortunately, we disagree with the referee\u2019s idea\/opinion\/suggestion<\/u>. We believe that \u2026<\/p>\n

We disagree with the reviewer on this topic. We believe that \u2026.<\/p>\n

We have to say that \u2026<\/p>\n

The reviewer \u2026 However, that is not the case here. In our opinion\/experience<\/u> \u2026<\/p>\n

 <\/p>\n

Hakemin yorumunun konuyla alakas\u0131z oldu\u011funu belirtmek i\u00e7in:<\/strong><\/p>\n

Unfortunately\/However<\/u>, the argument\/point<\/u> raised by the reviewer is irrelevant to the topic.<\/p>\n

 <\/p>\n

Hakemin sizin ifade etti\u011finizi tam anlamad\u0131\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnd\u00fc\u011f\u00fcn\u00fcz\u00fc belirtmek i\u00e7in:<\/strong><\/p>\n

We believe that the reviewer did not conceive our intent …<\/p>\n

We believe that the referee misunderstood\/misinterpreted<\/u> \u2026.<\/p>\n

 <\/p>\n

Kendi d\u00fc\u015f\u00fcncenizi savunmak i\u00e7in:<\/strong><\/p>\n

We believe that \u2026<\/p>\n

As we see \u2026<\/p>\n

Our results indicate that \u2026<\/p>\n

Our results are still valid as \u2026<\/p>\n

\u00a0<\/strong><\/p>\n

Kendi d\u00fc\u015f\u00fcncenizi kaynak bilgisi ile desteklemek i\u00e7in:<\/strong><\/p>\n

Evidence from the literature indicates\/suggests<\/u> that our proposition is true. In Dorrestein et al<\/em>. (2019), the authors have found \u2026<\/p>\n

The literature supports our opinion. In Gul et al<\/em>. (2019), the authors have found \u2026.. similar to our study. Also, Topal et al.<\/em> (2021), in their study performed on diabetic rats, found that \u2026.., which is consistent with our findings. Therefore, we believe that \u2026<\/p>\n

\u00a0<\/strong><\/p>\n

Yap\u0131lan de\u011fi\u015fikliklerle ilgili ifadeler:<\/strong><\/p>\n

The sentence was rewritten for better understanding.<\/p>\n

Suggested change was done.<\/p>\n

We revised the text as requested.<\/p>\n

The suggested part was omitted.<\/p>\n

Detailed information was added as requested.<\/p>\n

More recent literature was added.<\/p>\n

 <\/p>\n

Metinde yapt\u0131\u011f\u0131n\u0131z i\u015faretlemeleri ifade etmek i\u00e7in kullanabilece\u011finiz ifadeler:<\/strong><\/p>\n

Changes in the manuscript are indicated\/marked\/shown<\/u> in bold and red font.<\/p>\n

Changes in the text are highlighted in yellow.<\/p>\n

We highlighted the changes in yellow.<\/p>\n<\/div>\n

 <\/p>\nRevizyonlar sonras\u0131 makalenizi g\u00f6nderirken edit\u00f6re yazabilece\u011finiz mektup:<\/strong><\/span>

\n

 <\/p>\n

Dergiye g\u00f6nderdi\u011finiz makaleniz yay\u0131na kabul edildi, ancak hakemlerin ele\u015ftirileri ve istekleri do\u011frultusunda de\u011fi\u015fiklikler yapman\u0131z istendi. Yapt\u0131\u011f\u0131n\u0131z revizyon sonras\u0131 makalenizi dergiye g\u00f6nderirken edit\u00f6re y\u00f6nelik bir mektup yazman\u0131z gerekebilir. A\u015fa\u011f\u0131da makalenizi revizyon sonras\u0131 dergiye g\u00f6nderirken edit\u00f6re yazabilece\u011finiz \u00f6rnek bir mektubu bulabilirsiniz. E\u011fer bu mektubu dosya olarak eklemek yerine bir kutucu\u011fa mesaj olarak yazman\u0131z gerekirse mektubun ilgili k\u0131sm\u0131n\u0131 kopyala-yap\u0131\u015ft\u0131r y\u00f6ntemi ile kullanabilirsiniz:<\/p>\n

Revizyon sonras\u0131 edit\u00f6re yazabilece\u011finiz mektup \u00f6rne\u011fini word dosyas\u0131 olarak indir:<\/a><\/span><\/p>\n

 <\/p>\n

*********************<\/p>\n

Dear Editor,<\/p>\n

Enclosed please find the revised version of our manuscript entitled \u201cEffects of a novel substance A on blood pressure of hypertensive geriatric patients\u201d written by Grinwis GC, van Garderen E, and Dorrestein GM. All the changes and corrections suggested by the reviewers were performed. Attached we send our manuscript with marked revisions and also our point-by-point response to the reviewers\u2019 comments.<\/p>\n

We hope that our manuscript is now suitable for publication in Journal of XXX.<\/p>\n

We look forward to hearing from you soon.<\/p>\n

Sincerely yours,<\/p>\n

 <\/p>\n

Prof.Dr. Guy C. Grinwis<\/p>\n

*********************<\/p>\n<\/div>\n

 <\/p>\nHakemlik mi yap\u0131yorsunuz? Makale hakk\u0131nda yazarlara yazabilece\u011finiz \u00f6rnek c\u00fcmleler: (YAPIM A\u015eAMASINDA)<\/strong><\/span>

\n

 <\/p>\n

Haz\u0131rlan\u0131yor.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAYFA YAPIM A\u015eAMASINDA. HEN\u00dcZ SON HAL\u0130N\u0130 ALMADI.            <\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6705","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/pages\/6705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6705"}],"version-history":[{"count":31,"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/pages\/6705\/revisions"}],"predecessor-version":[{"id":7134,"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=\/wp\/v2\/pages\/6705\/revisions\/7134"}],"wp:attachment":[{"href":"https:\/\/www.ingilizcemakaleyazimi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}